人工智能与医疗保健专业人员互动：助力生命科学领域更智能的运营.pdf

1、 2025,Amazon Web Services,Inc.or its affiliates.All rights reserved.2025,Amazon Web Services,Inc.or its affiliates.All rights reserved.2025,Amazon Web Services,Inc.or its affiliates.All rights reserved.AI and HCP EngagementPowering Smarter Life Sciences Field OperationsIND203Nihir ChadderwalaSr.AI/M

2、L Solutions Architect Global Life SciencesPierre de MalliardSr.AI/ML Solutions ArchitectGlobal Life Sciences 2025,Amazon Web Services,Inc.or its affiliates.All rights reserved.3Market changes affecting sales engagementsP H A R M A C E U T I C A L S A L E S E N G A G E M E N T S A T A C R I T I C A L

3、 I N F L E C T I O N P O I N T-Delayed revenue Delayed revenue from extended onboarding cycles-Lost market share Lost market share from ineffective engagement-Missed opportunities Missed opportunities in shrinking launch windows-Competitive disadvantage Competitive disadvantage without AI adoptionBu

4、siness Impact-HCPs are limiting or restricting sales rep access-Several months to achieve full rep productivity-30%of rep time spent on activity other than selling-Sales reps overwhelmed by data sourcesMarket Challenges 2025,Amazon Web Services,Inc.or its affiliates.All rights reserved.4Sales Repres

5、entative Role EvolutionSales Rep interactions with physicians have becoming increasingly challenging,with more limited engagement opportunities and more tedious processes,resulting in a need to evolve the traditional sales approach.Decreased Access to InsightEngagements are increasingly limited,with

6、 covid forcing a transition from in-person to virtual interactions and+55%of health system-owned physician practices banning Sales Reps altogetherIncreased Complexity of EngagementIncreased complexity of drug portfolios requires Sales Reps to have deeper understanding of more complex treatments for